- Home
- CFSB vs ACRV Comparison
CFSB vs ACRV Comparison
Compare CFSB & ACRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CFSB
- ACRV
- Stock Information
- Founded
- CFSB 1889
- ACRV 2018
- Country
- CFSB United States
- ACRV United States
- Employees
- CFSB N/A
- ACRV N/A
- Industry
- CFSB Major Banks
- ACRV Medicinal Chemicals and Botanical Products
- Sector
- CFSB Finance
- ACRV Health Care
- Exchange
- CFSB Nasdaq
- ACRV Nasdaq
- Market Cap
- CFSB 51.6M
- ACRV 36.1M
- IPO Year
- CFSB N/A
- ACRV 2022
- Fundamental
- Price
- CFSB $13.61
- ACRV $1.05
- Analyst Decision
- CFSB
- ACRV Buy
- Analyst Count
- CFSB 0
- ACRV 7
- Target Price
- CFSB N/A
- ACRV $17.60
- AVG Volume (30 Days)
- CFSB 25.4K
- ACRV 728.6K
- Earning Date
- CFSB 04-29-2025
- ACRV 05-14-2025
- Dividend Yield
- CFSB N/A
- ACRV N/A
- EPS Growth
- CFSB N/A
- ACRV N/A
- EPS
- CFSB N/A
- ACRV N/A
- Revenue
- CFSB $7,484,000.00
- ACRV N/A
- Revenue This Year
- CFSB N/A
- ACRV N/A
- Revenue Next Year
- CFSB N/A
- ACRV N/A
- P/E Ratio
- CFSB N/A
- ACRV N/A
- Revenue Growth
- CFSB N/A
- ACRV N/A
- 52 Week Low
- CFSB $6.34
- ACRV $1.05
- 52 Week High
- CFSB $13.78
- ACRV $10.16
- Technical
- Relative Strength Index (RSI)
- CFSB 91.16
- ACRV 31.03
- Support Level
- CFSB $13.57
- ACRV $1.06
- Resistance Level
- CFSB $13.66
- ACRV $1.19
- Average True Range (ATR)
- CFSB 0.11
- ACRV 0.09
- MACD
- CFSB 0.52
- ACRV 0.05
- Stochastic Oscillator
- CFSB 97.24
- ACRV 0.00
About CFSB CFSB Bancorp Inc.
CFSB Bancorp Inc provides banking services. It offers a variety of financial services to individuals and small businesses through its offices in Quincy, Holbrook, and Weymouth. Its primary deposit products are savings, checking, and term certificate accounts, and its primary lending product is residential mortgage loans.The Company's loan portfolio includes residential real estate, commercial real estate, construction, and consumer loan segments. Residential real estate loans include classes for one- to four-family, multi-family, second mortgages and home equity lines of credit.
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.